Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Steven Shemesh Reaffirms Positive Outlook on Albertsons Companies

Elaine Mendonca by Elaine Mendonca
March 8, 2024
in Breaking News
0
Food Retailers Stock Market Today
0
SHARES
2
VIEWS
Share on FacebookShare on Twitter

On March 8, 2024, analyst Steven Shemesh from RBC Capital reaffirmed his positive outlook on Albertsons Companies (NYSE: ACI) by maintaining an Outperform rating. He slightly adjusted the price target from $24 to $23, in line with his previous recommendations made on February 13, 2024. While other analysts may have different price targets, averaging at $24.88 with a high estimate of $27.25, Shemesh’s consistent endorsement of Albertsons Companies demonstrates his continued optimism for the company’s performance.

ACI Stock Shows Positive Momentum with 0.48% Increase on March 8, 2024

On March 8, 2024, ACI stock showed some positive price momentum as it closed the trading day with a 0.48% increase. The stock opened at $20.74, which was $0.04 lower than its previous close. Throughout the day, ACI shares saw a modest increase of $0.10, bringing the closing price to $20.84.

ACI Worldwide Inc. (ACI) Stock Performance Analysis: Revenue Up, Net Income Down – March 8, 2024

On March 8, 2024, ACI Worldwide Inc. (ACI) stock performance was closely watched by investors and analysts as the company released its latest financial data. According to information sourced from CNN Money, ACI reported a total revenue of $77.65 billion for the past year, with a quarterly revenue of $18.56 billion.

Net income for ACI was reported at $1.51 billion for the past year, with a quarterly net income of $361.40 million.

Earnings per share (EPS) for ACI stood at $2.27 for the past year and $0.62 for the most recent quarter.

Overall, ACI’s financial performance on March 8, 2024, showed a mixed bag of results. While total revenue saw a modest increase from the previous year, net income experienced a decline over the same period. However, the company managed to increase its net income and EPS significantly from the previous quarter, indicating potential growth and improved financial health in the short term.

Investors and analysts will continue to closely monitor ACI’s performance in the coming quarters to assess its ability to sustain growth and profitability. The company’s ability to capitalize on emerging market opportunities and navigate challenges in the competitive landscape will be key factors influencing its stock performance in the future.

Tags: ACI
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Healthcare-and-IT

Boston Scientific A Decade of Exceptional Growth and Wealth Generation

Finance_Assets (2)

Analyst Ratings and Price Targets for T Rowe Price Group

Talking in a podcast

The Rise of Inspirational Podcasts: How Storytelling and Tea Sessions Are Shaping Online Communities

Recommended

Lockheed Martin Stock

Defense Giant Lockheed Martin Secures Billions in New Military Contracts

6 months ago
OKE stock news

Amalgamated Bank Increases Stake in CF Industries as Market Opinions Vary

3 years ago
IBM Stock

IBM’s AI Windfall Fails to Impress Stock Market

7 months ago
Blackstonecured Lending Fund Stock

Blackstone BDC Insider Purchase Defies Analyst Downgrades

4 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Figma Embraces Third-Party AI to Power Its Design Ecosystem

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

Evolent Health Bets on AI Leadership Amid Share Price Decline

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

Trending

Gossamer Bio Stock
Analysis

Gossamer Bio’s Pivotal FDA Meeting Looms in June 2026

by Kennethcix
March 25, 2026
0

The future of Gossamer Bio hinges on a critical regulatory discussion scheduled for June 2026. The biopharmaceutical...

SOXX ETF Stock

Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns

March 25, 2026
Fair Isaac Stock

Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

March 25, 2026
Figma Stock

Figma Embraces Third-Party AI to Power Its Design Ecosystem

March 25, 2026
BioNano Genomics Stock

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Gossamer Bio’s Pivotal FDA Meeting Looms in June 2026
  • Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns
  • Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com